ATF4 and Miyoshi myopathy: Consistent with the analysis in RPMI 8226 cells (Fig. 2D), doxorubicin treatment also induced the expression of target genes of the PERK-ATF4 branch in CD138+ MM patient cells (Supplementary Fig. S7).